cn3
Thursday, 17 November 2016
After Rough Patch,Gilead Shouldn't Succumb to Deal Pressure
The struggling biotech giant shouldn’t abandon its strategy in the face of bad news
from WSJ.com: Markets http://ift.tt/2gmLzaE
via https://ifttt.com/ IFTTT
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment